Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice

Rheumatology

Volumn 47, Issue 3, 2008, Pages 292-300

  Abe, K ^a,b   Wechs, S ^a   Kalaydjiev, S ^c,f   Franz, T J ^c   Busch, D H ^c   Fuchs, H ^a   Soewarto, D ^a   Behrendt, H ^d   Wagner, S ^a   Jakob, T ^d,e   de Angelis, M Hrabé ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Animal model; ENU; Inflammatory arthritis; Mouse mutant; Psoriatic arthritis

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5; RAG1 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GRANULOCYTE; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BONE MARROW CELLS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN E; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES;

EID: 39449112469     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem358     Document Type: Article

References (46)

1. Gregersen PK, Behrens TW. Genetics of autoimmune diseases - disorders of immune homeostasis. Nat Rev Genet 2006;7:917-28.
2. Nathan C. Points of control in inflammation. Nature 2002;420:846-52.
3. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43.
4. Hallert E, Husberg M, Jonsson D, Skogh T. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project). Rheumatology 2004;43:1374-82.
5. Feldmann M. Pathogenesis of arthritis: Recent research progress. Nat Immunol 2001;2:771-3.
6. Matzinger P. An innate sense of danger. Semin Immunol 1998;10:399-415.
7. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-5.
8. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
9. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
10. Nadeau JH, Balling R, Barsh G et al. Sequence interpretation. Functional annotation of mouse genome sequences. Science 2001;291:1251-5.
11. Sakaguchi N, Takahashi T, Hata H et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-60.
12. Jakob T, Köllisch GV, Howaldt M et al. Novel mouse mutants with primary cellular immunodeficiencies generated by genome-wide mutagenesis. J Allergy Clin Immunol 2008;121:179-184.
13. Negishi I, Motoyama N, Nakayama K et al. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 1995;376:435-8.
14. Yu P, Constien R, Dear N et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 2005;22:451-65.
15. Wang D, Feng J, Wen R et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000;13:25-35.
16. Hrabé de Angelis MH, Flaswinkel H, Fuchs H et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 2000;25:444-7.
17. Fuchs H, Schughart K, Wolf E, Balling R, Hrabé de Angelis M. Screening for dysmorphological abnormalities - a powerful tool to isolate new mouse mutants. Mamm Genome 2000;11:528-30.
18. Soewarto D, Fella C, Teubner A et al. The large-scale Munich ENU-mouse-mutagenesis screen. Mamm Ganome 2000;11:507-10.
19. Fuchs H, Lisse T, Abe K, Hrabé de Angelis M. Screening for bone and cartilage phenotypes in mice. In: Hrabé de Angelis M, Chambon P, Brown S, eds. Standards of mouse model phenotyping. Weinheim: Wiley-VCH, 2006;35-86.
20. Abe K, Fuchs H. Lisse T, Hans W, Hrabe de Angelis M. New ENU-induced semidominant mutation, Ali18, causes inflammatory arthritis, dermatitis, and osteoporosis in the mouse. Mamm Genome 2006;17:915-26.
21. Inzunza J, Midtvedt T, Fartoo M et al. Germfree status of mice obtained by embryo transfer in an isolator environment. Lab Anim 2005;39:421-7.
22. Mombaerts P, Iacomini J, Johnson RS, Herrop K, Tonegawa S, Papaloannau VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992:68:869-77.
23. Dietrich WF, Miller JC, Steen FG et al. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat Genet 1994;7(2 Spec No):220-45.
24. Kalaydjiev S, Franz T, Busch D. Mouse phenotyping: Immunology. In: Hrabé de Angelis M, Chambon P, Brown S, eds. Standards of mouse model phenotyping. Weinheim: Wiley-VCH, 2006;237-52.
25. Alessandrini F, Jakob T, Wolf A et al. Enu mouse mutagenesis: generation of mouse mutants with aberrant plasma IgE levels. Int Arch Allergy Immunol 2001;124:25-8.
26. Cohen PL, Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-69.
27. Schatz DG, Baltimore D. Uncovering the V(D)J recombinase. Cell 2004;116: S103-S106.
28. Butterfield JH, Leiferman KM, Gleich GJ. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): A novel eosinophilic disorder. Clin Exp Allergy 1993;23:571-80.
29. Zenarota P, Melillo L, Bisceglia M, Carotenuto M, Lomuto M. NERDS syndrome: An additional case report. Dermatology 1995;191:133-8.
30. Horai R, Saijo S, Tanioka H et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.
31. Courtenay JS, Dailman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980:283:666-8.
32. Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med 1985;162:1878-91.
33. Broide DH, Hoffman H, Sriramarao P. Genes that regulate eosinophilic inflammation. Am J Hum Genet 1999;65:302-7.
34. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-31.
35. Huston MM, Moore JP, Mettes HJ, Tavana G, Huston DP. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. J Immunol 1996;156:1392-401.
36. Szodoray P, Alex P, Frank MB et al. A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology 2006;45:1466-76.
37. Kollias G, Douni E, Kassiotis G, Kontoyiannis O. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 1999;169:175-94.
38. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 1991;10-4025-31.
39. Aidinis V, Plows D, Haralambous S et al. Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res Ther 2003;5:R140-57.
40. Gladman DD. Psoriatic arthritis. In: Kelley WN, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 5th edn. Philadelphia: W.B. Saunders, 1997;999-1005.
41. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
42. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001;167:1601-8.
43. Ferguson PJ, Bing X, Vasef MA et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006;38:41-7.
44. Grosse J, Chitu V, Marquardt A et al. Mutation of mouse Mayp/ Pstpip2 causes a macrophage autoinflammatory disease. Blood 2006;107:3350-8.
45. Yeung YG, Soldera S, Stanley ER. A novel macrophage actin-associated protein (MAYP) is tyrosine-phosphorylated following colony stimulating factor-1 stimulation. J Biol Chem 1998;273:30638-42.
46. Van Rooljen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.